See how top analysts and institutions rate KHC — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Morgan Stanley | Upgrade | Underweight → Equal-Weight | $29 | 2025-09-03 |
| JP Morgan | Resumed | Neutral | $27 | 2025-08-20 |
| Goldman | Upgrade | Sell → Neutral | $27 | 2025-06-25 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 0 | 1 | 18 | 0 | 1 |
| October 2025 | 0 | 1 | 18 | 0 | 1 |
| September 2025 | 0 | 2 | 17 | 1 | 1 |
| July 2025 | 0 | 2 | 17 | 1 | 1 |
The majority of institutional investors have issued a "Buy" rating for KHC, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
